Testing for H. pylori in adults with fatty liver disease
Part of Digestive system, Hormones & metabolism, Infections clinical trials.
This study checks if a common stomach bacteria (H. pylori) is linked to fatty liver disease. It may help doctors understand more about fatty liver and could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of fatty liver disease (confirmed by ultrasound or other imaging).
- You must not be pregnant.
- You must not have cancer or type 1 diabetes.
- You must not have had weight-loss (bariatric) surgery for fatty liver.
- You must not have recently used alcohol, steroids, antibiotics, acid-reducing pills, or contraceptive pills.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a specific gut bacteria (Ruminococcus gnavus) and the chemicals it makes are linked to a type of fatty liver disease called MAFLD. By joining, you'll help researchers understand this connection, which may lead to better treatments in the future.
This study follows adults with fatty liver to learn more about how it progresses and what patterns are common. It may help improve future ways of identifying and monitoring fatty liver.
This study is looking at whether people with fatty liver disease (MAFLD) also have high levels of uric acid in their blood, which is called hyperuricemia. It aims to find out how common this condition is and may help improve health care for people with fatty liver.
This study looks at adults with different long-term liver conditions that are associated with fatty liver. It helps researchers better understand these diseases and factors linked to them.
This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.
This study looks at whether certain gene activity in people with fatty liver disease can predict the risk of developing colorectal polyps. It may help doctors find high-risk patients earlier.
Hear when a new Helicobacter Pylori Infection Metabolic Dysfunction-Associated Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.